Impact Factor
3.44
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.47
1,347 total citations
h5-index
41
h5 depth signal
Cited share
60.3%
333 of 552
Total citations
1,347
Citation footprint
Metric signal
2.78
External metric anchor
Self-citation
7.3%
98 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,528
Canada
262
United Kingdom
234
Japan
201
Italy
186
Citing Fields of Research
Nervous System Disorders
1,228
Neuromuscular Disorders
1,078
Musculoskeletal Disorders
994
Neurodegenerative Disorders
378
Postural Control
237
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
13,467
Articles tracked across the journal lifetime
Indexed publication set
552
333 cited publications
Last 12 months
393
32.8 publications/month
Open access share
40.5%
159 OA publications in the last year
Leading citing country
United States
1,528 citing publications
Leading citing field
Nervous System Disorders
1,228 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v1n1,Jan./Feb. 1978-
v1n1,Jan./Feb. 1978-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neuromuscular Disorders
Nervous System Disorders
Musculoskeletal Disorders
Neurodegenerative Disorders
Issuing & Sponsoring Bodies
Contributor
American Association of Electromyography and Electrodiagnosis
Contributor
American Association of Electrodiagnostic Medicine
Contributor
American Association of Neuromuscular and Electrodiagnostic Medicine
Contributor
Muscular Dystrophy Association
Broad Categories
Neurology
Physiology
Musculoskeletal Disorders
Neuromuscular Disorders
Nervous System Disorders
Neurodegenerative Disorders
MeSH Descriptors
Electrodiagnosis
Muscular Diseases
Nervous System Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/mus.70428
Open DOI
Serum Mycophenolic Acid Levels and Infection Risk in Myasthenia Gravis
Introduction/Aims: Evidence linking serum mycophenolic acid (MPA) concentrations with safety outcomes in myasthenia gravis (MG) is limited. We evaluated whether single serum MPA concentrations were associated with clinically documented i...
02
DOI 10.1002/mus.70413
Open DOI
From Long‐Term to Trial‐Ready: 1.5‐Year Follow‐Up in an Established FSHD Cohort Highlights Limitations of Current Outcome Measures
Introduction/Aims: Identifying endpoints that are sensitive to change is crucial for clinical trial design in facioscapulohumeral muscular dystrophy (FSHD). This study adds follow‐up data to a previously published 5‐year natural history ...
03
DOI 10.1002/mus.70425
Open DOI
Ultrasound‐Guided Treatment of Peripheral Entrapment Mononeuropathies
High‐resolution neuromuscular ultrasound (US) is a valuable tool for the localization, diagnosis, and provision of conservative treatment to peripheral entrapment mononeuropathies. US‐guided interventions require careful coordination of ...
04
DOI 10.1002/mus.70418
Open DOI
The Expanding Therapeutic Landscape in Myasthenia Gravis
Myasthenia gravis (MG) is a rare autoimmune disorder caused by autoantibodies targeting postsynaptic proteins of the neuromuscular junction. Although conventional therapies can achieve remission or sufficient symptom control in most pati...
05
DOI 10.1002/mus.70435
Open DOI
The Efficacy and Safety of Tocilizumab in the Treatment of Refractory Ocular Myasthenia Gravis in Pediatric Patients
Introduction/Aims: Refractory pediatric ocular myasthenia gravis (OMG) remains difficult to manage. We evaluated tocilizumab's efficacy and safety in these patients. Methods: In this single‐center, retrospective analysis of prospectively...
06
DOI 10.1002/mus.70434
Open DOI
Electrophysiologic Demyelinating Features Are Common in Vasculitic Neuropathy: A Cohort of Biopsy‐Confirmed Cases
Introduction/Aims: Electrophysiologic features suggestive of demyelination have been reported in vasculitic neuropathy, complicating the diagnostic process, but their frequency is unknown. We aimed to determine the prevalence of demyelin...
07
DOI 10.1002/mus.70427
Open DOI
Statin Exposure and Survival Outcomes in Amyotrophic Lateral Sclerosis in an Asian Cohort
Introduction: Data from Asian cohorts on whether statin therapy affects amyotrophic lateral sclerosis (ALS) progression are limited. We examined whether statin exposure was associated with ALS disease duration or tracheostomy‐free surviv...
08
DOI 10.1002/mus.70431
Open DOI
The Duke Myasthenia Gravis Clinic Registry: IV . Does Race Affect the Outcome of Treatment of Myasthenia Gravis? A Single Center Retrospective Analysis
Introduction/Aims: Few studies have investigated the role of race in the long‐term outcome of patients with myasthenia gravis (MG). The aim of this study is to analyze clinical characteristics and treatment outcomes related to race in pa...
09
DOI 10.1002/mus.70433
Open DOI
Using High‐Field Magnetic Resonance Spectroscopy to Measure Muscle Glycogen in Patients With McArdle Disease
Introduction/Aims: Patients with McArdle disease demonstrate exercise intolerance with muscle contractures and episodic rhabdomyolysis. Additionally, some patients show progressive fat replacement of paraspinal and shoulder muscles with ...
10
DOI 10.1002/mus.70423
Open DOI
Join AANEM
Bibliographical & Catalog Notes
Some issues have supplements.
Also issued online.
Official journal of the American Association of Electromyography and Electrodiagnosis, <1984->; of the American Association of Electrodiagnostic Medicine. <Mar. 1990->; of the American Association of Neuromuscular and Electrodiagnostic Medicine, 2005-
"Supported in part by the Muscular Dystrophy Association," <2005->
Vol. 9, no. 1 (1986)19900917 Notice published Printed on acid-free paper